# The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

> **NCT07167550** · PHASE3 · RECRUITING · sponsor: **Tatchempharmpreparaty, JSC** · enrollment: 184 (estimated)

## Conditions studied

- Stroke
- Acute Stroke
- Ischemic Stroke
- Cerebrovascular Disorders
- Physiological Effects of Drugs

## Interventions

- **DRUG:** Dimephosphon®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07167550
- **Lead sponsor:** Tatchempharmpreparaty, JSC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-06
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-04-30
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07167550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07167550, "The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07167550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*